- Medical - Instruments & Supplies
- Healthcare
-
6.26
EPS
-
35.53
P/E
-
10.5B
MARKET CAP
-
0.61%
DIV YIELD
Company Overview
550 E SWEDESFORD RD,WAYNE PA 19087,610-225-6800
CEO
Mr. Liam J. Kelly
Employess
14500
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Website
https://www.teleflex.com
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. It provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site. The company also offers interventional products, which consists of various coronary catheters, structural heart therapies, and peripheral intervention and cardiac assist products that are used by interventional cardiologists and radiologists, and vascular surgeons; and Arrow branded catheters, Guideline and Trapliner catheters, the Manta Vascular Closure, and Arrow Oncontrol devices. It provides anesthesia products, such as airway and pain management products to support hospital, emergency medicine, and military channels; and surgical products, including metal and polymer ligation clips, and fascial closure surgical systems that are used in laparoscopic surgical procedures, percutaneous surgical systems, and other surgical instruments. The company also offers interventional urology products comprising the UroLift System, an invasive technology for treating lower urinary tract symptoms due to benign prostatic hyperplasia; and respiratory products, including oxygen and aerosol therapies, spirometry, and ventilation management products for use in various care settings. It provides urology products, such as catheters, urine collectors, and catheterization accessories and products for operative endourology; and bladder management services. The company serves hospitals and healthcare providers, medical device manufacturers, and home care markets. The company was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.
Next Earnings Date
Oct. 31, 2024
Ex Dividends date
Jun. 14, 2024
Dividend Date
May 14, 2024
YTD Performance
-11.12%
Fiscal Year End
12-31
IPO Date
1980-03-17
Growth Rates
(avg. rate of change) | 10 years | 5 years | 3 years | 1 year |
---|---|---|---|---|
Sales/Revenue | 5.78% | 3.97% | 5.44% | 6.57% |
EPS | 7.52% | 11.54% | 1.68% | -2.07% |
Equity | 8.78% | 11.82% | 10.00% | 10.42% |
Cash | -6.40% | -9.00% | -15.99% | -23.69% |
Return On Capital (ROIC) | 7.98% | 8.28% | 7.67% | 6.55% |
Debt
year (millions) | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Short Term Debt | 87.5 | 87.5 | 110 | 100 | 50 |
Long Term Debt | 1,840 | 1,740 | 1,860 | 2,460 | 1,960 |
LT Finance Leases | 111 | 120 | 116 | 86.1 | 101 |
Shares Outstanding | 47 | 46.9 | 46.8 | 46.5 | 46.2 |
Market Cap | 11,700 | 11,700 | 15,400 | 19,100 | 17,400 |
Price
News
Teleflex Announces Second Quarter 2024 Earnings Conference Call Information
2 monthsWAYNE, Pa., July 18, 2024 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its second quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, August 1, 2024.
globenewswire.comWhat Makes Teleflex (TFX) a New Buy Stock
2 monthsTeleflex (TFX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
zacks.comTFX vs. SONVY: Which Stock Is the Better Value Option?
2 monthsInvestors with an interest in Medical - Instruments stocks have likely encountered both Teleflex (TFX) and SONOVA HOLDING (SONVY). But which of these two stocks presents investors with the better value opportunity right now?
zacks.comThis Medical Devices Stock Has Several Catalysts, Says Bullish Analyst
3 monthsTeleflex Inc TFX benefited in the first quarter from the surge in the interventional segment and other tailwinds.
benzinga.comIs it Wise to Hold Teleflex (TFX) Stock in Your Portfolio Now?
3 monthsTeleflex (TFX) holds strong momentum in the Interventional arm and a favorable solvency. Yet, macroeconomic impacts and competitive environment trigger concerns.
zacks.comUS FDA classifies recall of Teleflex's inflatable devices as 'most serious'
3 monthsThe U.S. Food and Drug Administration classified a recall of Teleflex's inflatable devices that increase blood supply to the heart muscle as "most serious".
reuters.comTeleflex's (TFX) Urolift Drives Market Share, Macro Woes Stay
4 monthsThe commercialization of Teleflex's (TFX) UroLift in Japan has been a significant step toward making this therapy more broadly available to men suffering from BPH.
zacks.comHere's Why Teleflex (TFX) is a Strong Value Stock
4 monthsWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.comWhy Teleflex (TFX) is a Top Momentum Stock for the Long-Term
4 monthsThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.comTeleflex (TFX) is a Top-Ranked Growth Stock: Should You Buy?
4 monthsThe Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
zacks.comWhy Teleflex (TFX) is a Top Value Stock for the Long-Term
4 monthsWhether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
zacks.comTeleflex (TFX) Expands Vascular Access Portfolio With New Launch
4 monthsTeleflex (TFX) debuts the new Arrow EZ-IO Intraosseous Access Procedure Tray.
zacks.com